Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
166 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bankstown-Lidcombe Hospital
Bankstown, New South Wales, Australia
- Campbelltown Hospital
Campbelltown, New South Wales, Australia
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Icon Cancer Centre - Wesley
South Brisbane, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- One Clinical Research
Nedlands, Western Australia, Australia
- Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, Flemish Brabant, Belgium
- Universitair Ziekenhuis Gent
Ghent, Oost-Vlaanderen, Belgium
- Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan
Bruges, West-Vlaanderen, Belgium
- Zna Stuivenberg
Antwerp, Belgium
- Zna Stuivenberg - Satelite
Antwerp, Belgium
- University Multiprofile Hospital for Active Treatment Sveti George - Base 1
Plovdiv, Bulgaria
- Specialized Hospital for Active Treatment of Hematological Diseases - Ead Sofia
Sofia, Bulgaria
- University Multiprofile Hospital for Active Treatment Aleksandrovska
Sofia, Bulgaria
- University Multiprofile Hospital for Active Treatment St. Ivan Rilski
Sofia, Bulgaria
- University Multiprofile Hospital for Active Treatment - Prof. Dr. Stoyan Kirkovich
Stara Zagora, Bulgaria
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Lakeridge Health
Oshawa, Ontario, Canada
- Research Institute of the Mcgill University Health Centre
Montreal, Quebec, Canada
- Vseobecna Fakultni Nemocnice V Praze
Prague, Prague, Czechia
- Fakultní Nemocnice Hradec Králové
Hradec Králové, Czechia
- Fakultní Nemocnice Olomouc
Olomouc, Czechia
- Aarhus Universitetshospital
Aarhus N, Central Jutland, Denmark
- Tang Severinsen, Marianne
Aalborg, North Denmark, Denmark
- Institut Bergonié
Bordeaux, Aquitaine, France
- Centre Hospitalier Universitaire Estaing
Clermont-Ferrand, Aubergne, France
- Centre Hospitalier Lyon-Sud
Pierre-Bénite, Auvergne-Rhône-Alpes, France
- Hôpital Morvan
Brest, Brittany Region, France
- Chu de Nîmes - Institut de Cancérologie Du Gard
Nîmes, Gard, France
- Hôpital Emile Muller
Mulhouse, Grand Est, France
- Hôpital Huriez
Lille, Hauts-de-France, France
- Hôpital Bretonneau
Tours, Indre-et-Loire, France
- Hôpital L'Archet - Chu Nice
Nice, PACA, France
- Centre Hospitalier Universitaire D'Angers
Angers, Pays de la Loire Region, France
- Centre Hospitalier Universitaire de Saint-Étienne
Saint-Priest-en-Jarez, Pays de la Loire Region, France
- Hôpital Cochin
Paris, Île-de-France Region, France
- Hôpital Universitaire Pitié Salpêtrière
Paris, Île-de-France Region, France
- Hôpital Saint-Louis
Paris, France
- Kliniken Ostalb - Stauferklinikum Schwäbisch Gmünd
Mutlangen, Baden-Wurttemberg, Germany
- Marien Hospital Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Mar 2021
- Primary completion
- 20 Feb 2026
- Completion
- 31 Mar 2028
- Last update posted
- 9 Apr 2026
- Registered enrollment
- 353
- Registry id
- NCT04562389
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.